ReviewPathologie (Heidelberg, Germany)2023

New treatment options for metastatic HER2-low breast cancer : Consequences for histopathological diagnosis.

Carsten Denkert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.